Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | m52gg | — |
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 2G273 | — |
accidental overdose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of accidental overdose in a 2-month-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 2G273, expiry date 15-APR-2027) for prophylaxis. Co-suspect products included DTPa (Infanrix) (batch number m52gg, expiry date 07-SEP-2026) for prophylaxis. On 21-APR-2025, the patient received the 1st dose of Pediarix and the 1st dose of Infanrix. On 21-APR-2025, an unknown time after receiving Pediarix and Infanrix, the patient experienced accidental overdose (Verbatim: accidental overdose). The outcome of the accidental overdose was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-APR-2025 The reporter stated that a 2 months female baby received Pediarix and Infanrix on the same clinic day, which led to accidental overdose.